Assisting Clinical Decisions for Scarcely Available Treatment via Disentangled Latent Representation

• URL: http://arxiv.org/abs/2307.03315v1
• Date: Thu, 6 Jul 2023 22:02:33 GMT
• Title: Assisting Clinical Decisions for Scarcely Available Treatment via Disentangled Latent Representation
• Authors: Bing Xue, Ahmed Sameh Said, Ziqi Xu, Hanyang Liu, Neel Shah, Hanqing Yang, Philip Payne, Chenyang Lu
• Abstract summary: Treatment Variational AutoEncoder (TVAE) is a novel approach for individualized treatment analysis. TVAE is specifically designed to address the modeling challenges like ECMO with strong treatment selection bias and scarce treatment cases. We evaluate TVAE on two real-world COVID-19 datasets: an international dataset collected from 1651 hospitals across 63 countries, and a institutional dataset collected from 15 hospitals.
• Score: 5.1828964748013275
• License: http://creativecommons.org/licenses/by-sa/4.0/
• Abstract: Extracorporeal membrane oxygenation (ECMO) is an essential life-supporting modality for COVID-19 patients who are refractory to conventional therapies. However, the proper treatment decision has been the subject of significant debate and it remains controversial about who benefits from this scarcely available and technically complex treatment option. To support clinical decisions, it is a critical need to predict the treatment need and the potential treatment and no-treatment responses. Targeting this clinical challenge, we propose Treatment Variational AutoEncoder (TVAE), a novel approach for individualized treatment analysis. TVAE is specifically designed to address the modeling challenges like ECMO with strong treatment selection bias and scarce treatment cases. TVAE conceptualizes the treatment decision as a multi-scale problem. We model a patient's potential treatment assignment and the factual and counterfactual outcomes as part of their intrinsic characteristics that can be represented by a deep latent variable model. The factual and counterfactual prediction errors are alleviated via a reconstruction regularization scheme together with semi-supervision, and the selection bias and the scarcity of treatment cases are mitigated by the disentangled and distribution-matched latent space and the label-balancing generative strategy. We evaluate TVAE on two real-world COVID-19 datasets: an international dataset collected from 1651 hospitals across 63 countries, and a institutional dataset collected from 15 hospitals. The results show that TVAE outperforms state-of-the-art treatment effect models in predicting both the propensity scores and factual outcomes on heterogeneous COVID-19 datasets. Additional experiments also show TVAE outperforms the best existing models in individual treatment effect estimation on the synthesized IHDP benchmark dataset.

Related papers

• Predicting Treatment Response in Body Dysmorphic Disorder with Interpretable Machine Learning [0.4604003661048266]
  Body Dysmorphic Disorder (BDD) is a highly prevalent and frequently underdiagnosed condition. We employ multiple machine learning approaches to predict treatment outcomes. Treatment credibility emerged as the most potent predictor.
  arXiv  Detail & Related papers  (2025-03-13T17:39:10Z)
• Individualised Treatment Effects Estimation with Composite Treatments and Composite Outcomes [13.925793826373706]
  Estimating individualised treatment effect (ITE) remains a fundamental problem in causal inference. Previous work in causal machine learning for ITE estimation is limited to simple settings, like single treatments and single outcomes. We propose a novel and innovative hypernetwork-based approach, called emphH-Learner, to solve ITE estimation under composite treatments and composite outcomes.
  arXiv  Detail & Related papers  (2025-02-12T10:41:21Z)
• ISLES'24: Improving final infarct prediction in ischemic stroke using multimodal imaging and clinical data [3.2816454618159008]
  This work presents the ISLES'24 challenge, which addresses final post-treatment stroke infarct prediction from pre-interventional acute stroke imaging and clinical data. The contributions of this work are two-fold: first, we introduce a standardized benchmarking of final stroke infarct segmentation algorithms through the ISLES'24 challenge; second, we provide insights into infarct segmentation using multimodal imaging and clinical data strategies.
  arXiv  Detail & Related papers  (2024-08-20T16:01:05Z)
• Estimating treatment effects from single-arm trials via latent-variable modeling [14.083487062917085]
  Single-arm trials, where all patients belong to the treatment group, can be a viable alternative but require access to an external control group. We propose an identifiable deep latent-variable model for this scenario. Our results show improved performance both for direct treatment effect estimation as well as for effect estimation via patient matching.
  arXiv  Detail & Related papers  (2023-11-06T10:12:54Z)
• Heterogeneous Treatment Effect Estimation for Observational Data using Model-based Forests [0.0]
  We propose modifications to model-based forests to address the confounding issue in observational data. We found that this strategy reduces confounding effects in a simulated study with various outcome distributions. We demonstrate the practical aspects of HTE estimation for survival and ordinal outcomes by an assessment of the potentially heterogeneous effect of Riluzole on the progress of Amyotrophic Lateral Sclerosis.
  arXiv  Detail & Related papers  (2022-10-06T11:49:39Z)
• DESCN: Deep Entire Space Cross Networks for Individual Treatment Effect Estimation [7.060064266376701]
  Causal Inference has wide applications in various areas such as E-commerce and precision medicine. This paper proposes Deep Entire Space Cross Networks (DESCN) to model treatment effects from an end-to-end perspective.
  arXiv  Detail & Related papers  (2022-07-19T01:25:31Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Disentangled Counterfactual Recurrent Networks for Treatment Effect Inference over Time [71.30985926640659]
  We introduce the Disentangled Counterfactual Recurrent Network (DCRN), a sequence-to-sequence architecture that estimates treatment outcomes over time. With an architecture that is completely inspired by the causal structure of treatment influence over time, we advance forecast accuracy and disease understanding. We demonstrate that DCRN outperforms current state-of-the-art methods in forecasting treatment responses, on both real and simulated data.
  arXiv  Detail & Related papers  (2021-12-07T16:40:28Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• Hemogram Data as a Tool for Decision-making in COVID-19 Management: Applications to Resource Scarcity Scenarios [62.997667081978825]
  COVID-19 pandemics has challenged emergency response systems worldwide, with widespread reports of essential services breakdown and collapse of health care structure. This work describes a machine learning model derived from hemogram exam data performed in symptomatic patients. Proposed models can predict COVID-19 qRT-PCR results in symptomatic individuals with high accuracy, sensitivity and specificity.
  arXiv  Detail & Related papers  (2020-05-10T01:45:03Z)
• DTR Bandit: Learning to Make Response-Adaptive Decisions With Low Regret [59.81290762273153]
  Dynamic treatment regimes (DTRs) are personalized, adaptive, multi-stage treatment plans that adapt treatment decisions to an individual's initial features and to intermediate outcomes and features at each subsequent stage. We propose a novel algorithm that, by carefully balancing exploration and exploitation, is guaranteed to achieve rate-optimal regret when the transition and reward models are linear.
  arXiv  Detail & Related papers  (2020-05-06T13:03:42Z)
• Estimating Counterfactual Treatment Outcomes over Time Through Adversarially Balanced Representations [114.16762407465427]
  We introduce the Counterfactual Recurrent Network (CRN) to estimate treatment effects over time. CRN uses domain adversarial training to build balancing representations of the patient history. We show how our model achieves lower error in estimating counterfactuals and in choosing the correct treatment and timing of treatment.
  arXiv  Detail & Related papers  (2020-02-10T20:47:36Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.